Alephoson Biopharmaceuticals

ALEPHOSON BIOPHARMACEUTICALS LIMITED is a technology-based private company focused on the research and development of innovative drug delivery technologies to address unmet medical needs. By leveraging disruptive and proprietary next-generation Cell Penetrating Protein Alternatives (CePPA) technology, we are striving to overcome the limitations of current treatments for serious ophthalmic diseases by developing topical eye drop alternatives to intravitreal (back of the eye) injections. At ALEPHOSON, we understand the critical role vision plays in patients' quality of life, the frustration ophthalmologists face when unable to successfully treat patients, and the potential burden long-term treatment may impose on patients and their families. We are committed to developing new ocular therapies to help patients achieve the best possible vision throughout their lives. Our management team and board have extensive experience in discovering, evaluating, developing, and commercializing pharmaceuticals. These new therapies may include improvements to existing drugs or entirely new molecules.